Catalyst Wire Dossier Catalyst Wire Dossier

Beclomethasone dipropionate (HFA-BDP)

beclomethasone dipropionate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Beclomethasone dipropionate (HFA-BDP), covering 2016-12-01 to 2016-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408) [Phase 3]

See pricing